Company: IOBT
Filing Date: 2025-08-11
Form Type: 8-K
Source: 0001193125-25-177471
Chunk: 3

Company: IO Biotech, Inc.
Filing Date: 2025-08-11
Form: 8-K
Item: Item 8.01
Chunk 3
---
 these results, the Company plans to meet with the regulatory authorities to discuss the totality of data and determine next steps for submission of a Biologics License Application (BLA) for the treatment of advanced melanoma to the U. S. Food and Drug Administration (FDA). Additionally, the Company plans to present more detailed results from the IOB-013study at an upcoming medical meeting.

  Item 9.01.      Financial Statements and Exhibits.  

(d) Exhibits

  Exhibit      Exhibit Description                                                          
                                                                                            
   Number                                                                                   
     99.1      IO Biotech, Inc. Press Release, dated as of August 11, 2025                  
 ────────────────────────────────────────────────────────────────────────────────────────────
     99.2      IO Biotech, Inc. Presentation                                                
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)